P6.291 Rates of Adverse Events
P6.304 Argentinian Validation of the
P6.316 Temporal Dot Sign of
Stanley, Caroline Knight, Robert Stein
Daniel Sanchez, Eugenia Lopez, Clara Pinasco, Teresa Torralva, Alfredo Thomson, Maria Roca, Bruno Diana
Niranjan Singh, Sushma Yerram
in the Very Old: A Community Anticoagulation Clinic Study —Michael
P6.292 Early cerebral ischemic
events in symptomatic carotid stenosis are related to plaque inflammation —Chi Hsien Tan, Prakash Paliwal, Arvind Sinha, Eric Ting, Hock Luen Teoh, Bernard Chan, Vijay Sharma
P6.293 Aspirin use is associated
with decreased initial stroke severity in patients with acute ischemic stroke: Pilot study —Judd Jensen, Jan Leonard, Raphael Bar-Or, Leonard Rael, Russell Bartt, Jeffrey Wagner, David Bar-Or
CARDIOVASCULAR ISSUES IN ISCHEMIC STROKE
Aggie Figures Learning Test (AFLT) —
P6.305 Application of
Neuropsychological Measures for Patients with Amyotrophic Lateral Sclerosis (ALS) —Megan Parmenter, Mona Shahbazi, Dale Lange
P6.306 Neural basis of the
Addenbrooke’s Cognitive Examination III: an 18F-fluorodeoxyglucose positron emission tomography study. —Jordi A
Matias-Guiu, Maria Nieves Cabrera-MartÌn, Alicia Perez-Perez, Maria Valles-Salgado, Teresa Rognoni, Ana Cortes-Martinez, Teresa Moreno-Ramos, Jose Carreras, Jorge MatiasGuiu
P6.307 Improving Cognitive
in patients with cryptogenic stroke —
Screening Accuracy and Efficiency II: Application for Parkinson’s disease —
P6.295 Acute Stroke Therapy in
P6.308 Improving Cognitive
Sung Cho, Lucy Zhang, Ken Uchino, Dolora Wisco
Davis, William Souillard-Mandar, Rhoda Au, Dana Penney
P6.294 Predictors of atrial fibrillation Swetha Renati, Leonardo Almeida, Sonisha Warren, Christina Wilson
Infective Endocarditis—Case Series and Systematic Review —Robert Marquardt,
Randall Davis, William Souillard-Mandar, Rhoda Au, Dana Penney
Screening Accuracy and Efficiency for Minimally Impaired Individuals —Randall
P6.296 Acute neurologic
P6.309 Is minimal effort effortless? A
Horn, Magdy Selim, Lester Leung
Bruno Lenne, Pascal Antoine
complications of cardiac catheterization: clinical syndromes and outcomes —Sarah
P6.297 Characterizing Ischemic
Stroke and Hemorrhagic Conversion in Infectious Endocarditis —Robert
Marquardt, Sung Cho, Lucy Zhang, Ken Uchino, Dolora Wisco
qualitative analysis of response bias on memory assessment —Rekha Barthelemy,
P6.310 Rapidly progressive dementia
as a manifestation of neurosyphilis: case report —Kelly Meza Capcha, Humberto Huapaya, Sheila Suarez, MarÌa Meza
Transient Global Amnesia—Case series and Literature review —Jagkirat Singh,
P6.317 Diagnostic Challenges
of Fahr’s Disease: A Case Report — Ellen Fitzmorris, Esther Bit-Ivan, Borna Bonakdarpour
P6.318 Congenital Extra-hepatic
porto-systemic shunt presenting with adult-onset fluctuating myelopathy and encephalopathy : a case report —Danielle Lux, Anna Naito, Neil Munro, Harikrishnan Sreedharan
P6.319 Retrospective Study
of Neurocognitive Outcomes in Autoimmune Encephalitis —Julien Hebert, Maria Gamoias Simoes, Claude Steriade, David Tang-Wai, Richard Wennberg
P6.320 Longitudinal Assessment
of Neuropsychological Performance in Patients with Idiopathic REM Sleep Behavior Disorder —Youngsin Jung,
Tanis Ferman, Mary Machulda, Julie Fields, Jonathan Graff-Radford, David Jones, Rodolfo Savica, David Knopman, Erik St. Louis, Michael Silber, Ronald Petersen, Bradley Boeve
P6.321 Does the cerebellum help
solve the “signal-to-noise” problem in sensory processing: evidence from vestibular activation in patients with cerebellar dysfunction —Raquel GalvanGarza, Yulia Valko, Kilian Dahlem, Ajitkumar Mulavara, Jeremy Schmahmann, Richard Lewis
P6.322 Cognitive Fatigue in Multiple Sclerosis: Objective Measures and Structural Correlates —Christos Bakirtzis,
P6.298 Altered Cerebral
BEHAVIORAL AND COGNITIVE NEUROLOGY: PHARMACOLOGICAL EFFECTS
Marina Boziki, Ioannis Nikolaidis, Panagiotis Ioannidis, Dimitris Karacostas, Nikolaos Grigoriadis
Alexandra Reynolds, Nicholas Morris, Joshua Willey
P6.311 Impact of Psychotropic drugs
P6.323 Cardiovascular risk factors
Hemodynamics Causing Neurologic Dysfunction in VA-ECMO —Lauren Dunn,
P6.299 Emergent MRI during a Stroke
on Seizure threshold —Muhammad Bhatti, Parshaw Dorriz
Alert. Single center experience. —Nidhi
P6.312 The Acute and Long Term
P6.300 Retrospective analysis of
Arsen Hunanyan, Adriana Azar, April Ratliff, Mohamad Mikati
Kapoor, Courtney Iser, David Thompson, Margaret Elaine Haxton, Evgeny Sidorov
Spinal Cord Infarction after Aortic Repair —Gino Gialdini, Alexander Merkler, Neal Parikh, Michael Lerario, Abhinaba Chatterjee, Hooman Kamel
P6.301 Association between stroke
subtype and left ventricular dysfunction evolution over time —Yi Li, Timothy Fitzgibbons, Nils Henninger
BEHAVIORAL AND COGNITIVE NEUROLOGY: DIAGNOSTIC TESTING
P6.302 Cognitive Neurology Toolkit:
An iPad App for Mental Status Testing — Daniel Press, Isabella Aslarus, Ellison Lim, Seth Amarasinghe, Chun Lim
P6.303 Validation of an ecological
Diana, Paula Carolina Torres, Vladimiro Sinay, Pagani Cassara Fatima, Maria Roca
P6.313 Persistence of Effect of
Dextromethorphan Hydrobromide/ Quinidine Sulfate (DM/Q) for Pseudobulbar Affect (PBA): Results from a 12-Week Open-Label Extension (OLE) Study —Benjamin Brooks, Erik Pioro, Paul
Maria-Beatriz Jurado, Michael Palacios, Daniel Moreno-Zambrano, Carlos Cevallos, Ibeth Regato Ugalde, Ximena Gamboa, MariaCarolina Duarte, Carlos Penaherrera, Leonardo Tamariz, Rocio Santibanez
P6.324 Lesion Mapping of Bilateral
Motor Threshold in Chronic Post-Stroke Hemiparesis —Aaron Boes, Douglas
Labar, Amy Kuceyeski, Alvaro Pascual-Leone, Michael Fox, Dylan Edwards
P6.325 Selective Deficits in Prosody
Shin, Ryan Law, Andrea Formella
after Right Hemisphere Stroke —Harry
BEHAVIORAL AND COGNITIVE NEUROLOGY: COGNITIVE DEFICITS IN NEUROLOGICAL DISORDERS
P6.326 Measurement of Social
Sutherland-Foggio, Amy Wright, Rajani Sebastian, Argye Hillis
Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study —
P6.314 Distinct Behavioural
Tom Burke, Marta Pinto Grau, Katie Lonergan, Marwa Elamin, Peter Bede, Emmet Costello, Orla Hardiman, Niall Pender
Elamin, Marta Pinto Grau, Katie Lonergan, Peter Bede, Mark Heverin, Alice Vajda, Russell McLaughlin, Niall Pender, Orla Hardiman
P6.327 What Makes Right
P6.315 Curious Case of Starvation
Sutherland-Foggio, Corey Demsky, Amy Wright, Sadhvi Saxena, Donna Tippett, Daniel Fogerty, Argye Hillis
Phenotypes in ALS: A Population Based Factor Analysis —Tom Burke, Marwa
Induced Wernicke’s Encephalopathy — Sharjeel Panjwani, Mohammad Humayun, Noor Pirzada
Hemisphere Stroke Patients Sound Emotionless? —Alexandra Basilakos, Harry
P6.328 Combined Mania and Visual-
Auditory Hallucinations in a Patient with Isolated Right Thalamic Hemorrhage: the
Parunyou Julayanont, Doungporn Ruthirago, Khondoker Alam, Yazan Alderazi
DISEASE MODIFYING THERAPY FOR MULTIPLE SCLEROSIS: EFFICACY AND CLINICAL TRIAL OUTCOMES I
P6.329 Efficacy of Interferon β-1a
Subcutaneously Three Times Weekly According to Baseline EDSS/Duration, EDSS, and MSSS Subgroups: Post Hoc Analysis of PRISMS Data —Eric
Williamson, Hao Zhang, Julie Aldridge, Scott Baver, Regina Berkovich
P6.330 Safety and efficacy in
patients receiving natalizumab therapy in Hungary —Tunde Csepany, Gabor Lovas, Krisztina Bencsik, Csilla Rozsa, Krisztina Kovacs, Samuel Komoly, Peter Barsi, Zoltan Mor
P6.331 The Phase 2b SYNERGY
Trial: Analyses of Acute Brain Lesion Recovery —Karleyton Evans, Robert Brown,
Jie Li, Lei Xu, Douglas Arnold, Elizabeth Fisher, Robert Naismith, Alexey Boyko, Nikolaos Evangelou, Martin Valis, Nancy Richert, Diego Cadavid, Michelle Mellion
P6.332 Early Fingolimod Treatment
Improves Disease Outcomes at 2 and 4 years in Patients with RelapsingRemitting Multiple Sclerosis —Reinhard Hohlfeld, Ludwig Kappos, Davorka Tomic, Diego Silva, Kathrin Ringwald, Daniela Piani Meier, Krzysztof Selmaj
P6.333 Safety and Efficacy of
Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice: Interim Analysis of ESTEEM —Nicholas Everage, Claudia Prada, Shifang Liu, Konstantin Balashov, Richard Macdonell, Joerg Windsheimer, Kathryn Giles
P6.334 Evaluating the Effect of
Teriflunomide on Cortical Gray Matter Atrophy in the Phase 3 TOPIC Study —
Robert Zivadinov, Michael Dwyer, Ellen Carl, Kathinathan Thangavelu, Steven Cavalier, Niels Bergsland
P6.335 Long term efficacy and safety
of Dimethyl Fumarate: A 3 year follow-up in a single MS center —Peiqing Qian, Julia Joo, James Scanlan, James Bowen
P6.336 Clinical Trial Design protocol Tolervit-MS: TOLerance-induction with dendritic cells treated with VITamin-D3 and loaded with myelin peptides in Multiple Sclerosis patients. —Silvia
Presas, M José Mansilla, Juan Navarro, Aina Teniente-Serra, Bibiana Quirant-Sanchez, Ascension Lopez, Susana Inoges, Felipe Prosper, Eva Martinez-Caceres, Cristina Ramo
P6.337 Effects of Ocrelizumab on
Neurofilament Light Chain and Other Biomarkers of Neuroinflammation and Neurodegeneration in MS: OBOE Study Design —Ann Herman, Bruno Musch,
Christopher Harp, Jian Han, Beverly Assman, Damian Fiore, Donna Masterman, Anne Cross, Amit Bar-Or
P6.338 Efficacy of Ocrelizumab on
Brain MRI Outcomes in Patients with Early Relapsing Multiple Sclerosis: Pooled Analysis of the OPERA Studies —
Fast and easy registration · AAN.com/view/AM17 135
FRIDAY
test of incidental learning useful at medical office —Agostina Galiani, Bruno
Toxicity of Dextromethorphan in the Developing Brain —Jordan Richardson,
contribute differentially to cognitive functioning in middle-aged adults —
Behavioral Disconnection Syndrome —
Poster Sessions
Presenters Stand by Posters 4:00 p.m.–5:30 p.m.